-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Biz5UpXNJuzrx7ZnwA6PN78FkhWLED+Sig7T4qwJIQZTBBNQxXSDvoz8Xi6tiA9a R08IhDEtLzgbU2uTPkQnsA== 0001125282-06-001404.txt : 20060302 0001125282-06-001404.hdr.sgml : 20060302 20060302164221 ACCESSION NUMBER: 0001125282-06-001404 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060228 FILED AS OF DATE: 20060302 DATE AS OF CHANGE: 20060302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCGEE BRIAN CENTRAL INDEX KEY: 0001284144 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 06660374 BUSINESS ADDRESS: STREET 1: 201 BRIDGELAND AVE STREET 2: TORONTO CITY: ONTARIO CANADA M6A 1Y7 STATE: A6 ZIP: 00000 BUSINESS PHONE: 416 246 4000 MAIL ADDRESS: STREET 1: 201 BRIDGELAND AVE STREET 2: TORONTO CITY: ONTARIO CANDA M6A 1Y7 STATE: A6 ZIP: 00000 4 1 form.xml X0202 4 2006-02-28 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001284144 MCGEE BRIAN 201 BRIDGELAND AVE TORONTO ONTARIO CANDA M6A 1Y7 A6 00000 ONTARIO, CANADA 1 Common Stock 2006-02-28 4 P 0 70000 2.21 A 70000 D Brian McGee 2006-03-02 -----END PRIVACY-ENHANCED MESSAGE-----